Document is current

Any future updates will be listed below

Progression-Free Survival and Response Rate in Neuroendocrine Liver-Metastasized Patients, Treated with 111In-Octreotide

Crossref DOI link: https://doi.org/10.1007/978-3-030-70773-6_23

Published Online: 2021-05-31

Published Print: 2021

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark